Many Americans are not reaching national physical-activity targets, but the available figures need a narrower interpretation than a claim that sedentary behavior is driving a new wave of heart disease. The American Heart Association's 2025 statistical update found that fewer than half of US adults achieved at least 150 minutes of weekly physical activity.
The gap was wider among children. Less than 19% reached the recommendation of at least 60 minutes of physical activity each day. The association highlighted those figures in connection with National Walking Day, a public campaign built around an accessible form of movement.
These are participation estimates, not a study showing that screen-based work, workplace stress or prolonged sitting caused a recent rise in cardiovascular events. Physical inactivity is an established cardiovascular risk factor, but this particular evidence does not measure the proposed national causal chain.
The Numbers Describe Missed Targets
The adult and child figures summarize whether people met recommended amounts of activity. They do not say that everyone below a threshold has the same risk, or that a single type of activity is required. Nor do they establish that an evening workout cannot offset sitting earlier in the day.
The American Heart Association's campaign suggested practical ways to add movement, including walking during a phone call or between meetings. Those suggestions are general public-health messaging. They are not individualized treatment instructions and do not replace clinical advice for people with symptoms or medical limitations.
A separate finding cited in the original report came from research on the Mediterranean diet. It concerns a possible biological pathway, not US activity levels. Keeping the two evidence streams separate is necessary because one is a population statistic and the other is a small observational biomarker study.
The Diet Study Included 49 Older Adults
The Frontiers in Nutrition study analyzed 49 people with non-valvular atrial fibrillation. Their average age was 78.4 years, and 57% were women. Twenty participants had high adherence to a nine-item Mediterranean-diet questionnaire; 29 had low-to-medium adherence.
Participants with high adherence had higher blood levels of the mitochondrial microproteins Humanin and SHMOOSE. Humanin was also inversely associated with markers related to oxidative stress. The researchers proposed that these signals could help explain part of the Mediterranean diet's relationship with cardiovascular health.
The design cannot show that the diet produced those biomarker differences. It was cross-sectional, used a convenience sub-cohort, relied on a brief diet questionnaire and did not account for physical activity or several other potential confounders. The authors explicitly said further work is needed to determine whether the associations are causal.
A Biomarker Is Not a Clinical Outcome
The study did not randomly assign diets, track heart attacks or demonstrate that increasing either microprotein prevents cardiovascular disease. Its participants were older adults with atrial fibrillation, so the results cannot be assumed to apply to the general US population or to children.
The paper is useful because it identifies a testable mechanism. It is not a basis for claiming that specific foods activate a proven cellular shield. That stronger conclusion would require controlled dietary interventions and evidence that changes in the biomarkers translate into better clinical outcomes.
The Evidence Supports Action, Not Exaggeration
Low activity participation is a genuine public-health problem, and walking can be one practical route to more movement. But a campaign statistic cannot carry claims about national disease causation, occupational stress or the effect of uninterrupted sitting unless those questions were actually measured.
The hard conclusion is that the movement gap is clear while the dramatic causal story is not. Public-health agencies do not need inflated claims to justify safer places to walk, more realistic opportunities for activity or better research. When prevalence data and a 49-person pilot are made to sound like proof of a nationwide mechanism, advocacy stops being evidence and becomes marketing.